These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20037177)

  • 1. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
    Onuigbo MA
    Nephrol Dial Transplant; 2010 Apr; 25(4):1344-5. PubMed ID: 20037177
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
    Baweja S; Holt SG; McMahon LP
    Nephrol Dial Transplant; 2011 May; 26(5):1752-3; author reply 1753. PubMed ID: 21471329
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination treatment and renal function in patients with chronic kidney disease.
    Renke M; Rutkowski P; Tylicki L; Rutkowski B
    J Renin Angiotensin Aldosterone Syst; 2010 Jun; 11(2):146-7. PubMed ID: 20223790
    [No Abstract]   [Full Text] [Related]  

  • 4. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
    Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blocking the renin-angiotensin system in chronic kidney disease].
    Segura J
    Nefrologia; 2004; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
    [No Abstract]   [Full Text] [Related]  

  • 6. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S
    Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of renal disease--can we forget about inhibition of the renin-angiotensin system?
    Mann JF; McClellan WM; Kunz R; Ritz E
    Nephrol Dial Transplant; 2006 Sep; 21(9):2348-51; discussion 2352-3. PubMed ID: 16822789
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease.
    Kolesnyk I; Struijk DG; Dekker FW; Krediet RT
    Neth J Med; 2010 Jan; 68(1):15-23. PubMed ID: 20103817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual renin-angiotensin system blockade and kidney disease.
    Parving HH; Brenner BM; McMurray JJ; de Zeeuw D; Haffner SM; Solomon SD; Chaturvedi N; Pfeffer MA
    J Am Coll Cardiol; 2009 Jul; 54(3):278-9; author reply 279-80. PubMed ID: 19589445
    [No Abstract]   [Full Text] [Related]  

  • 10. The hazards of dual renin-angiotensin blockade in chronic kidney disease.
    Ku E; Park J; Vidhun J; Campese V
    Arch Intern Med; 2009 Jun; 169(11):1015-8. PubMed ID: 19506167
    [No Abstract]   [Full Text] [Related]  

  • 11. The Renin Report.
    Sica DA; Ichihara A
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):247-51. PubMed ID: 17347934
    [No Abstract]   [Full Text] [Related]  

  • 12. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Ruilope LM
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation.
    Baker WL; White CM
    Conn Med; 2007 Apr; 71(4):205-9. PubMed ID: 17487005
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease.
    Toto R; Palmer BF
    Am J Nephrol; 2008; 28(3):372-80. PubMed ID: 18073461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
    Ram CV; Deedwania PC
    Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
    Fronczyk A; Majkowska L
    Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ARBs or ACEIs, that is the question.
    Ishigami T; Uchino K; Umemura S
    Hypertens Res; 2006 Nov; 29(11):837-8. PubMed ID: 17345782
    [No Abstract]   [Full Text] [Related]  

  • 20. Moving beyond angiotensin II to also target aldosterone?
    Little WC; Kirkman PM
    J Am Coll Cardiol; 2009 Aug; 54(6):513-4. PubMed ID: 19643311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.